Clinical_Rounds_in_Endocrinology_Volume_II_-_Pediatric_Endocrinology

364 a c b Fig. 10.15 A 35-year-old male presented with primary infertility. ( a ) He was short and had history of early pubarche ...

365 How to differentiate between TART and Leydig cell tumor? TART and Leydig cell tumor mimics each other, and failure to cons ...

366 tone. The rationale of rhGH therapy in these individuals is to counteract the effects of glucocorticoids on linear growth. T ...

367 range suggests overtreatment with GnRH agonists. This is because prepuber- tal gonads produce minor quantities of gonadal st ...

368 What is the role of bilateral adrenalectomy in patients with CAH? Bilateral adrenalectomy is a therapeutic option in patie ...

369 When to treat a patient with non-classical CAH due to 21α-hydroxylase defi ciency? Children with NCCAH having early pubarc ...

370 What are the characteristic features of CAH due to 11β-hydoxylase defi ciency? 11 β-hydoxylase defi ciency is the second m ...

371 therapy, even in those who have hypertension prior to therapy. This paradox occurs because after initiation of glucocorticoi ...

372 to reduced synthesis of testosterone as a consequence of impaired activity of CYP17A1 in testes, whereas genital ambiguity i ...

373 What is the clinical relevance of “backdoor pathway” in CAH? P450 oxidoreductase is required for the electron transfer to ...

374 How to assign the gender in a newborn with 46,XX CAH due to 21α - hydroxylase defi ciency? A newborn with 46,XX CAH due to ...

375 What are the appropriate timings for genital reconstruction surgery in a girl with genital ambiguity due to CAH? In girls ...

376 Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics. 2006;118:e934. Krone N, Arlt W ...

© Springer India 2016 377 A. Bhansali et al., Clinical Rounds in Endocrinology, DOI 10.1007/978-81-322-2815-8_11 11 Multiple End ...

378 40 mEq/L (N <15), fasting plasma insulin 10.2 μIU/ml, C-peptide 3.19 ng/ml with cor- responding plasma glucose 98 mg/dl, ...

379 a c d b Fig. 11.1 (a) A 42-year-old male presented with proptosis. (b) CEMRI sella showing giant pitu- itary adenoma. (c) CE ...

380 e f g Fig. 11.1 (continued) 11 Multiple Endocrine Neoplasia ...

381 11.2 Stepwise Analysis In the index patient with this clinical and biochemical profile, the diagnosis of multi- ple endocrin ...

382 detected at the age of 42 years. Multiglandular parathyroid involvement is character- istic of MEN1 syndrome either as parat ...

383 type 3). Recently, type 4 MEN syndrome has also been described. This classi- fication is based on involvement of specific en ...